Suppr超能文献

健康受试者单次口服消旋体后羟氯喹的对映体选择性处置。

Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects.

作者信息

Ducharme J, Fieger H, Ducharme M P, Khalil S K, Wainer I W

机构信息

McGill University, Department of Oncology, Montreal General Hospital, Quebec, Canada.

出版信息

Br J Clin Pharmacol. 1995 Aug;40(2):127-33. doi: 10.1111/j.1365-2125.1995.tb05768.x.

Abstract
  1. Stereoselectivity in the disposition of hydroxychloroquine was investigated in 23 healthy males following a single oral dose of 200 mg racemic HCQ (rac-HCQ) sulphate. Total concentrations (R+S) and R/S ratios of HCQ and its metabolites were measured by stereoselective h.p.l.c. 2. HCQ was detected in whole blood and urine, up to 91 and 85 days after dosing, respectively. Metabolites could not be detected in whole blood while in urine detectable concentrations were still present after 85 days. The blood concentrations of HCQ enantiomers were measurable until 168 h post-dose. 3. R(-)-HCQ accounted for 62 +/- 3% (mean +/- s.d.) of the AUC of rac-HCQ AUC. The elimination half-life of S(+)-HCQ (457 +/- 122 h) was significantly shorter than that of R(-)-HCQ (526 +/- 140 h), partly due to its faster urinary excretion and hepatic metabolism. Its renal clearance was twice that of R(-)-HCQ (4.61 +/- 4.01 vs 1.79 +/- 1.30 1 h-1), and metabolites derived from the S-isomer represented 80-90% of the urinary recovery of the dose. 4. Over 85 days, 4.4 +/- 2.9 and 3.3 +/- 1.8% of the dose was recovered in urine as unchanged S(+)-HCQ and R(-)-HCQ, respectively. For the first 2 weeks, S(+)-HCQ excretion rate clearly surpassed that of R(-)-HCQ whereas afterwards the inverse was observed. However, since the first 2 weeks account for 95% of rac-HCQ renal excretion, the total urinary excretion of S(+)-HCQ clearly surpassed that of R(-)-HCQ.(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 在23名健康男性单次口服200毫克消旋硫酸羟氯喹(rac-HCQ)后,研究了羟氯喹处置过程中的立体选择性。通过立体选择性高效液相色谱法测量了HCQ及其代谢物的总浓度(R+S)和R/S比值。2. 在给药后分别长达91天和85天,全血和尿液中检测到了HCQ。全血中未检测到代谢物,而尿液中在85天后仍存在可检测浓度。给药后168小时内可测量到HCQ对映体的血药浓度。3. R(-)-HCQ占rac-HCQ AUC的62±3%(平均值±标准差)。S(+)-HCQ的消除半衰期(457±122小时)明显短于R(-)-HCQ(526±140小时),部分原因是其尿排泄和肝脏代谢更快。其肾清除率是R(-)-HCQ的两倍(4.61±4.01对1.79±1.30 1小时-1),S-异构体衍生的代谢物占给药后尿液回收量的80-90%。4. 在85天内,分别有4.4±2.9%和3.3±1.8%的给药剂量以未变化的S(+)-HCQ和R(-)-HCQ形式在尿液中回收。在最初的2周内,S(+)-HCQ的排泄率明显超过R(-)-HCQ,而之后则观察到相反情况。然而,由于最初2周占rac-HCQ肾排泄的95%,S(+)-HCQ的总尿排泄量明显超过R(-)-HCQ。(摘要截短至250字)

相似文献

引用本文的文献

7
4-Aminoquinoline compounds from the Spanish flu to COVID-19.从西班牙流感到 COVID-19 的 4-氨基喹啉类化合物。
Biomed Pharmacother. 2021 Mar;135:111138. doi: 10.1016/j.biopha.2020.111138. Epub 2020 Dec 15.
9
Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19.降低风险:新型冠状病毒肺炎暴露前预防
Infect Drug Resist. 2020 Oct 19;13:3689-3694. doi: 10.2147/IDR.S264831. eCollection 2020.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验